A guide for easy- and difficult-to-treat hypertension

被引:17
|
作者
Schmieder, Roland E. [1 ]
Volpe, Massimo [2 ,3 ]
Waeber, Bernard [4 ]
Ruilope, Luis M. [5 ,6 ]
机构
[1] Univ Hosp Erlangen, Dept Hypertens & Nephrol, Erlangen, Germany
[2] Univ Roma La Sapienza, St Andrea Hosp, Clin & Mol Med Dept, Cardiol Unit, I-00185 Rome, Italy
[3] IRCCS Neuromed, Pozzilli, Italy
[4] CHU Vaudois, Div Physiopathol Clin, CH-1011 Lausanne, Switzerland
[5] Hosp 12 Octubre, Hypertens Unit, E-28041 Madrid, Spain
[6] Univ Autonoma Madrid, Dept Publ Hlth & Prevent Med, Madrid, Spain
关键词
Hypertension; Treatment algorithm; Renal denervation; RENAL SYMPATHETIC DENERVATION; FIXED-DOSE COMBINATIONS; HIGH-BLOOD-PRESSURE; DOUBLE-BLIND; HIGH-RISK; BARORECEPTOR STIMULATION; RESISTANT HYPERTENSION; OLMESARTAN MEDOXOMIL; AMLODIPINE; THERAPY;
D O I
10.1016/j.ijcard.2013.12.125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the blood pressure (BP) of many patients can be controlled using standard combinations, treatment of hypertension frequently represents a clinical challenge to the primary care physician. This article will review best practices for managing patients with easy-and difficult-to-treat hypertension, including preferred antihypertensive combinations, optimizing adherence and persistence, recognizingwhite-coat hypertension, and intensifying therapy for treatment-resistant patients. Each physicianmust decide based on his or her own level of experience at what point a patient becomes too challenging and would benefit fromreferral to a hypertension specialist for more intensive management and to complete the exclusion of secondary forms of arterial hypertension. With intensive pharmacotherapy, many patients with difficult-to-treat hypertension can achieve BP control. If it fails, interventional strategies (e. g., renal denervation) are a valid option to get BP controlled. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 50 条
  • [41] Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
    Chrysant, S. G.
    Lee, J.
    Melino, M.
    Karki, S.
    Heyrman, R.
    JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (11) : 730 - 738
  • [42] CHARACTERISTICS OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
    Takanashi, S.
    Kaneko, Y.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 612 - 613
  • [43] Psychological interventions for difficult-to-treat depression
    Williams, Chris
    Ridgway, Nicola
    BRITISH JOURNAL OF PSYCHIATRY, 2012, 201 (04) : 260 - 261
  • [44] Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
    S G Chrysant
    J Lee
    M Melino
    S Karki
    R Heyrman
    Journal of Human Hypertension, 2010, 24 : 730 - 738
  • [45] Red plaques and difficult-to-treat asthma
    Wieshuber, Christine
    Wendel, Ana-Maria
    Trautmann, Axel
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (04): : 312 - 313
  • [46] Dupilumab utility in difficult-to-treat asthma
    Walsh, Garry M.
    IMMUNOTHERAPY, 2019, 11 (04) : 261 - 264
  • [47] The difficult-to-treat psychiatric patient.
    Sandson, NB
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2002, 190 (09) : 650 - 651
  • [48] Tanezumab improves difficult-to-treat OA
    Sarah Onuora
    Nature Reviews Rheumatology, 2020, 16 : 296 - 296
  • [49] EASY AND DIFFICULT TO TREAT EPILEPSIES
    Sander, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 643 - 643
  • [50] Difficult to Find, Easy to Treat!
    Anam, Omer
    Raza, Ali
    Neshatian, Leila
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1130 - S1130